Arotech (ARTX) Sees FY Revenue of $85 to $87 Million
Tweet
Share
E-mailGet Alerts ARTX Hot Sheet
Price: $3.00 --0%
Financial Fact:
Operating income (loss): 1.83M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Operating income (loss): 1.83M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Arotech Corporation (NASDAQ: ARTX) today provided guidance with respect to its full year 2013 results.
Based on current backlog, customer discussions and order expectations, Arotech expects that 2013 revenues will be in the range of $85 to $87 million. EBITDA for 2013 is expected to be between $2.9 million and $3.4 million.
Based on current backlog, customer discussions and order expectations, Arotech expects that 2013 revenues will be in the range of $85 to $87 million. EBITDA for 2013 is expected to be between $2.9 million and $3.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
- nCino, Inc. (NCNO) Reports Q2 EPS of $0.05, Offers Guidance
- Vivakor raises 2026 supply and trading outlook to $3.5 billion
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
